The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterizing the clinical and genomic features of androgen indifferent prostate cancer.
 
Jack Masur
No Relationships to Disclose
 
Krzysztof Wierbilowicz
No Relationships to Disclose
 
Aakrosh Ratan
Consulting or Advisory Role - MedGenome
Research Funding - AstraZeneca/MedImmune
 
Adanma Ayanambakkam
Consulting or Advisory Role - AVEO; Pfizer/Astellas
 
Michelle Churchman
No Relationships to Disclose
 
Saum Ghodoussipour
Honoraria - Janssen Research & Development
Consulting or Advisory Role - Janssen Research & Development
 
Laura Graham
No Relationships to Disclose
 
George Grass
Employment - Moffitt Cancer Center and Research Institute
Stock and Other Ownership Interests - Editas Medicine; G1 Therapeutics; GlycoMimetics; Halozyme; Intellia Therapeutics; Lantheus Medical Imaging
Consulting or Advisory Role - MyCareGorithm
Research Funding - Artera
Patents, Royalties, Other Intellectual Property - MODELING VARIABILITY IN RADIOSENSITIVITY AND TUMOR IMMUNE CONTEXTURE TO PERSONALIZE RADIOTHERAPY
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Research Funding - Acrotech Biopharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Lilly (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); Immunocore (Inst); Incyte (Inst); LSK BioPharma (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); QED Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); Viralytics (Inst)
(OPTIONAL) Uncompensated Relationships - Astellas Pharma
 
Sean Kern
No Relationships to Disclose
 
Jennifer King
No Relationships to Disclose
 
Zin Myint
Research Funding - Merck (Inst)
 
Seyi Oderinde
No Relationships to Disclose
 
Robert Rounbehler
No Relationships to Disclose
 
Bodour Salhia
Leadership - CpG Diagnostics
Stock and Other Ownership Interests - CpG Diagnostics Inc
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patents filed and pending at University of Southern California
(OPTIONAL) Uncompensated Relationships - CpG Diagnostics
 
Eric Singer
Consulting or Advisory Role - Aura Biosciences
Research Funding - Astellas Medivation
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genzyme; Gilead Sciences; Janssen; Myovant Sciences; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Bryce Paschal
Employment - Define Therapeutics
 
Paul Viscuse
No Relationships to Disclose